BioSpace News Archive

Emergent BioSolutions Inc. reported financial results for the three and nine months ended September 30, 2020 and updated its full year 2020 guidance.

Geron Corporation, a late-stage clinical biopharmaceutical company, reported financial results for the third quarter ended September 30, 2020.

Third quarter 2020 HEPLISAV-B® net product revenue highest since launch at $11.6 million, despite impact of COVID-19

BioLife Solutions, Inc., a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, announced financial results for the three and nine months ended September 30, 2020.

REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, announced it will present at the following November investor conferences, which will each be held in a virtual meeting format:

YUPELRI® (revefenacin) share of the nebulized COPD market increased to 17.4% through July 2020 (up from 16% in April 2020) and achieved brand profitability on a stand-alone basis

Natera, Inc., a pioneer and global leader in cell-free DNA testing, reported financial results for the third quarter ended September 30, 2020 and provided an update on recent business progress.

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, reported financial results for the quarter ended September 30, 2020, and provided an update on recent accomplishments and upcoming events.

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced it will host a conference call and webcast on Thursday, November 12, 2020 at 5:00 p.m. to discuss financial results and corporate developments for the third quarter ended September 30, 2020.

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation and left atrial appendage management, announced third quarter 2020 financial results.